• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿毒症毒素通过传统血液透析膜的转运。

Transport of uremic toxins through conventional hemodialysis membranes.

作者信息

Jörstad S, Smeby L C, Wideröe T E, Berg K J

出版信息

Clin Nephrol. 1979 Oct;12(4):168-73.

PMID:509791
Abstract

Human mononuclear phagocytes cultured in vitro were tested after preincubation with uremic plasma dialyzed in vitro and the effects of pre and post hemodialysis plasma were compared with the effect of dialyzates equilibrated with uremic plasma in vivo. Factors in uremic blood plasma inhibiting phagocytosis of Candida albicans could not be removed by means of conventional hemodialysis with cuprophan (CPN) or polyacrylonitrile (PAN) membranes. Hemofiltrates of uremic blood plasma produced by PAN membranes caused a significant inhibition of phagocytes in our test system while CPN hemofiltrates did not.

摘要

体外培养的人单核吞噬细胞在与体外透析的尿毒症血浆预孵育后进行测试,并将血液透析前后血浆的作用与在体内与尿毒症血浆平衡的透析液的作用进行比较。尿毒症血浆中抑制白色念珠菌吞噬作用的因素不能通过使用铜仿膜(CPN)或聚丙烯腈(PAN)膜的常规血液透析去除。在我们的测试系统中,由PAN膜产生的尿毒症血浆血液滤过液对吞噬细胞有显著抑制作用,而CPN血液滤过液则没有。

相似文献

1
Transport of uremic toxins through conventional hemodialysis membranes.尿毒症毒素通过传统血液透析膜的转运。
Clin Nephrol. 1979 Oct;12(4):168-73.
2
Toxicity of middle molecules: clinical evaluation using a selective filtration artificial kidney.中分子物质的毒性:使用选择性滤过人工肾的临床评估
Artif Organs. 1981;4 Suppl:98-103.
3
Removal of uraemic toxins by haemofiltration with different membranes. The benefit of regenerating haemofiltrate using a newly developed system.使用不同膜进行血液滤过清除尿毒症毒素。利用新开发系统再生血液滤过液的益处。
Proc Eur Dial Transplant Assoc. 1979;16:212-7.
4
Removal of uremic toxins and regeneration of hemofiltrate by a selective dual hemofiltration artificial kidney (SEDUFARK) system.采用选择性双重血液滤过人工肾(SEDUFARK)系统清除尿毒症毒素及再生血液滤出液。
Clin Nephrol. 1980 Feb;13(2):85-92.
5
Transport of small, middle, and large molecular weight substances in a dual filtration artificial kidney.双滤过人工肾中小分子、中分子和大分子物质的转运
Artif Organs. 1981;4 Suppl:104-9.
6
New approaches to the removal of protein-bound toxins from blood plasma of uremic patients.从尿毒症患者血浆中去除蛋白结合毒素的新方法。
Artif Cells Blood Substit Immobil Biotechnol. 2007;35(3):287-308. doi: 10.1080/10731190701378618.
7
Plasma middle molecules in asymptomatic and "sick" uremic patients.无症状和“患病”尿毒症患者的血浆中分子物质
Artif Organs. 1981;4 Suppl:137-42.
8
In vitro cytotoxic properties of plasma samples from uremic patients.尿毒症患者血浆样本的体外细胞毒性特性
Clin Nephrol. 1982 May;17(5):247-53.
9
In vitro cytotoxic properties of plasma fractions from uremic patients.尿毒症患者血浆成分的体外细胞毒性特性。
Artif Organs. 1981;4 Suppl:68-70.
10
[Phagocyte function in uremic patients].
Verh K Acad Geneeskd Belg. 1991;53(3):189-201; discussion 201-3.

引用本文的文献

1
Candida bloodstream infections in hemodialysis recipients.血液透析患者的念珠菌血流感染。
Med Mycol. 2009;47(5):463-7. doi: 10.1080/13693780802369332.